DCM
WST icon

Davis Capital Management’s West Pharmaceutical WST Stock Holding History

Davis Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718 Buy
2
+1
+100% +$306 ﹤0.01% 546
2026
Q1 		$251 Hold
1
– – ﹤0.01% 519
2025
Q4 		$275 Hold
1
– – ﹤0.01% 506
2025
Q3 		$262 Buy
+1
New +$243 ﹤0.01% 526

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Davis Capital Management's WST Position: Q2 2026 in Review

Davis Capital Management increased its West Pharmaceutical (WST) stake by 100% in Q2 2026, buying an estimated $306 and bringing the position to 2 shares worth $718. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Davis Capital Management first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Davis Capital Management held 2 shares of West Pharmaceutical worth $718 as of Q2 2026.
  • Davis Capital Management bought 1 West Pharmaceutical share in Q2 2026, an estimated $306.
  • West Pharmaceutical made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #546 holding.
  • Davis Capital Management first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.